Subsidies
Subsidies
subsidy
| Title | Code of transcript | Funder | Beneficiary Entity | Call for applications | Date of award | Amount Awarded | Other Funds |
|---|---|---|---|---|---|---|---|
| Inflammatory Diseases | RD21/0002/0010 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Results-Oriented Cooperative Networks (RICORS) research | 16-12-2021 | 180.537,50€ | ERDF funds |
| SEHOP-PENCIL study- Personalised Medicine for Cancer in Children in Spain A Spanish nation-wide strategy to implement personalised medicine in children and adolescents with cancer A Spanish nation-wide strategy to implement personalised medicine in child | PMP21/00087 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Personalised Medicine | 16-12-2021 | 200.420,00€ | - |
| RICORS2040 | RD21/0005/0024 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Results-Oriented Cooperative Networks (RICORS) research | 16-12-2021 | 105.765,00€ | ERDF funds |
| network Inflammatory diseases | RD21/0002/0028 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Results-Oriented Cooperative Networks (RICORS) research | 16-12-2021 | 111.100,00€ | ERDF funds |
| Advanced therapies | RD21/0017/0009 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Results-Oriented Cooperative Networks (RICORS) research | 16-12-2021 | 94.947,60€ | ERDF funds |
| New targets and designs to improve CAR-T cell based immunotherapy against pancreatic cancer (CarPanTu) | PLEC2021-008094 | STATE INVESTIGATION AGENCY | University of Navarra | 2021 AEI research and development+i projects on strategic lines | 15-12-2021 | 100.042,00€ | MRR Funds |
| CARDIOPRINT_Advanced multifunctional 3D biofabrication for the generation of computer-engineered human-scale therapeutic cardiac tissue. | PLEC2021-008127 | STATE INVESTIGATION AGENCY | University of Navarra | 2021 AEI research and development+i projects on strategic lines | 15-12-2021 | 203.867,00€ | - |
| MSCA IF EF-ST 2020: Privateering: State-society collaboration for the mobilisation of military resources during the War of Jenkins Ear | PCI2021-122071-2B | MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES | University of Navarra | 2021 AEI Projects of partnership International - 2 | 15-12-2021 | 160.932,00€ | - |
| Tumor Immune Microenvironment (TIME) targeted therapy in paediatric brain cancer | PCI2021-122084-2B | MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES | University of Navarra | 2021 AEI Projects of partnership International - 2 | 15-12-2021 | 160.932,00€ | - |
| New non-invasive and ultra-sensitive methods for assessing minimal residual disease in multiple myeloma | PI21/01816 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Projects research | 03-12-2021 | 148.830,00€ | ERDF funds |
| Immunovirotherapy against paediatric osteosarcoma: preclinical analysis of Delta-24-RGDOX virus-based strategies. | PI21/00940 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Projects research | 02-12-2021 | 171.820,00€ | ERDF funds |
| #LabMeCrazy Science Film | 0011-3987-2021-000006 | GOVERNMENT OF NAVARRA | University of Navarra | 2021 GN Cosmos - Promotion of scientific culture | 02-12-2021 | 4.311,32€ | - |
| Total atrial reconstruction using cellularised Scaffold. Preclinical study of efficacy and tumourogenicity. | PI21/00531 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Projects research | 02-12-2021 | 111.320,00€ | ERDF funds |
| Science and Technology Week 2021 | 0011-3987-2021-000007 | GOVERNMENT OF NAVARRA | University of Navarra | 2021 GN Cosmos - Promotion of scientific culture | 02-12-2021 | 7.729,80€ | - |
| Study on the functional interaction between amylin and synuclein in vivo. Implication for neurodegeneration and new therapies in Parkinson's disease. | PI21/00259 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Projects research | 02-12-2021 | 171.820,00€ | ERDF funds |
| Serum markers in patients with congenital melanocytic nevus: clinicopathological correlation and Genetics. Possible pharmacological modulation. | PI21/01416 | HIGH SCHOOL CARLOS III HEALTH CENTRE | University of Navarra | 2021 AES Projects research | 02-12-2021 | 147.620,00€ | ERDF funds |
| Multiparametric cardiac magnetic resonance imaging for the detection of ischaemia, without the use of gadolinium | PI21/00578 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Projects research | 01-12-2021 | 65.340,00€ | ERDF funds |
| Neutrophil Extracellular Traps in the Solid Tumour Microenvironment: Towards a Biomarker for Immunotherapy. | PI21/01547 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Projects research | 01-12-2021 | 159.720,00€ | ERDF funds |
| In vivo imaging of the biodistribution of orally administered radiolabelled nanovaccines for infectious diseases (INNAVACORID) | PI21/01003 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2021 AES Projects research | 01-12-2021 | 117.370,00€ | ERDF funds |
| GV_EIMA2.0_MATRIZEAK_CWHITE | GV EDUCATION | EUSKO JAURLARITZA - BASQUE GOVERNMENT | University of Navarra | EIMA 2.0 Call for Proposals | 01-12-2021 | 25.000,00€ | - |
| Preclinical and translational development of an intratumoral immunotherapy strategy consisting of the combination of BO-112 and STING agonists. | PDC2021-121769-C22 | STATE INVESTIGATION AGENCY | University of Navarra | 2021 AEI research and development+i projects for proof-of-concept testing | 01-12-2021 | 23.000,00€ | - |
| F&F4sustainability. Fashion & Food synergy for sustainability. New courses and innovative digital tools in higher education | EUROPEAN COMMISSION | University of Navarra | KA 2 Cooperation partnerships in higher education | 01-12-2021 | 48.338,00€ | - | |
| Between freedom of expression and the right to honor: in search of linguistic criteria. | IJC2020-046166-I | STATE INVESTIGATION AGENCY | University of Navarra | 2020 AEI JUAN DE LA CIERVA INCORPORATION | 29-11-2021 | 97.800,00€ | - |
| 2020 scholarship Juan de la Cierva training (BECAJCF 22-23) | FJC2020-046252-I | STATE INVESTIGATION AGENCY | University of Navarra | 2020 AEI JUAN DE LA CIERVA TRAINING | 29-11-2021 | 52.600,00€ | - |
| GENOMIC PRECISION MEDICINE IN NEOPLASMS | PMP21/00015 | HIGH SCHOOL CARLOS III HEALTH CENTRE | University of Navarra | 2021 AES Personalised Medicine | 04-11-2021 | 213.000,00€ | MRR Funds |
| National Quantum Computing Plan (network Spanish Computing) | STATE INVESTIGATION AGENCY | University of Navarra | network Spanish Quantum Supercomputing | 01-11-2021 | 125.000,00€ | - | |
| TOXLEARN4EU_Toxicology Innovative Learning For Europe | EUROPEAN COMMISSION | University of Navarra | KA 2 Cooperation partnerships in higher education | 19-10-2021 | 38.552,00€ | - | |
| Annual plan of activities of the UCC+i at the University of Navarra | FCT-20-16125 | SPANISH FOUNDATION FOR SCIENCE AND TECHNOLOGY | University of Navarra | 2020 FECYT Promoting scientific culture | 13-10-2021 | 25.000,00€ | - |
| NEW LIME MORTARS WITH ADDITIVES AND MICRO-ENCAPSULATED PHASE CHANGE MATERIALS TO IMPROVE THE ENERGY EFFICIENCY AND THERMAL COMFORT OF ARCHITECTURAL ASSETS | PID2020-119975RB-I00 | STATE INVESTIGATION AGENCY | University of Navarra | 2020 AEI PROJECTS research and development+i (including Generation knowledge and Challenges research) | 29-09-2021 | 121.000,00€ | - |
| Drug incorporation into polymeric fibres for dermal release: application to the treatment of cutaneous leishmaniasis and skin infections | PID2020-112713RB-C21 | STATE INVESTIGATION AGENCY | University of Navarra | 2020 AEI PROJECTS research and development+i (including Generation knowledge and Challenges research) | 29-09-2021 | 84.700,00€ | - |
